In partnership with Dr Bart Dolmatch at Palo Alto Medical Foundation, the company developed the device in 2010.
Winter in India brings both beauty and health risks, particularly in urban areas. Respiratory issues, heart problems, and ...
With approval, the company can begin commercializing the device in the U.S. in 2025.
Vinod Kambli was admitted to a hospital in Thane after complaining of a urinary infection and cramps. However, after a ...
A PHASE 3 clinical trial, explorer8, has demonstrated the efficacy and safety of concizumab, a monoclonal antibody in ...
As the global population ages, the demand for regenerative therapies grows, yet replicating the natural complexity of the ...
Citrullinated fibrin is abundant in inflamed synovium Objective: To assess the diagnostic and prognostic value of antibodies against citrullinated fibrinogen (ACF), a soluble precursor of fibrin, in ...
Unique cell-impermeable1 design extends life-saving treatment for dialysis patientsMerit to host a WRAPSODY informational call on January 28, ...
Wellness influencers showed higher rates of vaccine opposition on social media compared to other users’ accounts, according to a new University of Michigan study.
Unique cell-impermeable1 design extends life-saving treatment for dialysis patientsMerit to host a WRAPSODY informational call on January 28, 2025 SOUTH JORDAN, Utah, Dec. 20, 2024 (GLOBE NEWSWIRE) ...